GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (OTCPK:GNHAF) » Definitions » Short Interest

Vifor Pharma AG (Vifor Pharma AG) Short Interest


View and export this data going back to 2013. Start your Free Trial

What is Vifor Pharma AG Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Vifor Pharma AG's Short Interest

For the Drug Manufacturers - Specialty & Generic subindustry, Vifor Pharma AG's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vifor Pharma AG's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vifor Pharma AG's Short Interest distribution charts can be found below:

* The bar in red indicates where Vifor Pharma AG's Short Interest falls into.


Vifor Pharma AG (Vifor Pharma AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (OTCPK:GNHAF) » Definitions » Short Interest
Comparable Companies
XSWX:SFZN XSWX:PPGN XTER:MRK ZTS TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 VTRS SHSE:600196 NBIX NSE:DIVISLAB SZSE:000963 HKSE:03692 XTAE:TEVA SZSE:000661 SZSE:300142 SHSE:600085
Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Website
https://www.viforpharma.com
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (Vifor Pharma AG) Headlines